Literature DB >> 4153405

Metabolism and disposition of hydralazine-14C in man and dog.

J M Lesser, Z H Israili, D C Davis, P G Dayton.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4153405

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


× No keyword cloud information.
  14 in total

Review 1.  Antihypertensive drugs: clinical pharmacology and therapeutic use.

Authors:  G L Wollam; R W Gifford; R C Tarazi
Journal:  Drugs       Date:  1977-12       Impact factor: 9.546

2.  Clinical pharmacokinetics of hydrallazine.

Authors:  T Talseth
Journal:  Clin Pharmacokinet       Date:  1977 Sep-Oct       Impact factor: 6.447

Review 3.  Influence of food on the bioavailability of drugs.

Authors:  A Melander
Journal:  Clin Pharmacokinet       Date:  1978 Sep-Oct       Impact factor: 6.447

Review 4.  Clinical pharmacokinetics of hydralazine.

Authors:  T M Ludden; J L McNay; A M Shepherd; M S Lin
Journal:  Clin Pharmacokinet       Date:  1982 May-Jun       Impact factor: 6.447

5.  Pharmacokinetics of hydralazine and its acid-labile hydrazone metabolites in relation to acetylator phenotype.

Authors:  D D Shen; J P Hosler; R L Schroder; D L Azarnoff
Journal:  J Pharmacokinet Biopharm       Date:  1980-02

6.  Disposition and metabolism of 3-hydrazino-6-[N,N-bis(2-hydroxyethyl)amino] pyridazine dihydrochloride in man.

Authors:  A Assandri; A Perazzi; G Buniva; V Pagani
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1979       Impact factor: 2.441

7.  Studies on hydralazine. III. Bioavailability of hydralazine in man.

Authors:  T Talseth
Journal:  Eur J Clin Pharmacol       Date:  1976       Impact factor: 2.953

8.  Studies on hydralazine. II. Elimination rate and steady-state concentration in patients with impaired renal function.

Authors:  T Talseth
Journal:  Eur J Clin Pharmacol       Date:  1976-09-30       Impact factor: 2.953

9.  Hydralazine pharmacokinetics and interaction with food: an evaluation of the dog as an animal model.

Authors:  H A Semple; Y K Tam; R T Coutts
Journal:  Pharm Res       Date:  1990-03       Impact factor: 4.200

10.  Comparative evaluation of the in vitro effects of hydralazine and hydralazine acetonide on arterial smooth muscle.

Authors:  K Barron; O Carrier; K D Haegele; A J McLean; J L McNay; P Du Souich
Journal:  Br J Pharmacol       Date:  1977-11       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.